ACE Program Information
Last updated Tuesday, November 18, 2008
Musculoskeletal Tumor ACEAbout the Tumor ACE Coordinators:
- Ernest U. Conrad III, M.D.
Professor & Co-Vice Chair Orthopaedics Services - UWMC
Director, Sarcoma Services - UWMC
Director, Pediatric Bone Tumor Clinic - CHMC - Jason Scott Weisstein, M.D.
Associate Professor
Address:
Department of Orthopaedics, Box 356500
School of Medicine
(206) 543-3690
Fax: (206) 685-3139
Institutions:
Profile and Educational Goals The University of Washington Musculoskeletal Tumor Service is
composed of two clinical services: an adult service at the University
of Washington Medical Center and a pediatric service at Children's
Hospital and Medical Center. Both services are extremely active and
center around coordinated multidisciplinary clinics managed by
orthopaedic surgery and medical oncology personnel in addition to
resident and fellow house staff. Weekly multidisciplinary conferences
are held with staff members from radiology, pathology and radiation
therapy. The adult and pediatric services are each coordinated by a
dedicated nurse oncologist, and the services conjointly evaluate
approximately 600 new patients per year (350 adults and 250 children).
The orthopaedic service carries out approximately 500 procedures per
year, including 100 osseous limb salvage procedures and 150 soft-tissue
sarcoma procedures.
Unique to our oncology program is its close relationship with the
Northwest Tissue Center. The Northwest Tissue Center serves the
Washington, Alaska, Montana and Idaho (WAMI) regions. It represents one
of the largest accredited tissue banks in North America. It is the only
tissue bank in the world that combines the resources of a major
university medical center with a regional organ-procurement agency and
a large non-profit blood center.
The Northwest Tissue Center was founded in 1988 as a collaboration
between the University of Washington Department of Orthopaedics, the
Puget Sound Blood Center, and the Northwest Kidney Foundation. Dr.
Conrad has served as both its co-director and medical director since
its inception.
The basic science research program associated with the
musculoskeletal tumor service collaborates with scientists located
primarily within the Department of Orthopaedics. There are multiple
genetic and molecular oncology studies currently in progress, in
addition to several prospective clinical studies for high-grade
malignancies and a comprehensive bone transplant immunology project.
The Advanced Clinical Experience (ACE) program was established in
1990 and, to-date, has remained a one-year fellowship involving
primarily clinical responsibilities. ACEs have access to a maximum of
$1,000 in book and travel funds during their fellowship year and are
protected from non-tumor activities within the Department of
Orthopaedics. Future plans can be made for an additional year of basic
science research within the department as those interests arise. The
educational goal of this ACE program is to train orthopaedic
oncologists with a strong interest in pathology and prospective
protocols. The surgical management taught emphasizes a balance between
allograft transplantation and modular implant reconstructions depending
on the age of the patient and the extent and location of the resection.
A Washington state medical license must be obtained prior to the
start date for each fellowship. At present, the program year commences
on the first of August. We are currently accepting applications for the Musculoskeletal Tumor
ACE position for 2010 -2011 year.
|